Patents - Global Data - Dimensions
Grant
Compounds for use in inducing myocardial perfusion recovery
Applicants
- Epoqe Pharma Aps
Abstract
A calcitonin gene-related peptide (CGRP) compound can be selected from N-alpha-[2-(2-{2-[(S)-4-carboxy-4-(17-carboxyheptadecanoylamino)-butyrylamino]ethoxy}ethoxy)acetyl][Ser1]alpha-human CGRP peptide (α-CGRP-analogue), or derivatives thereof; or N-alpha-[2-(2-{2-[(S)-4-carboxy-4-(17-carboxyheptadecanoylamino)butyryl-amino]-ethoxy}ethoxy)acetyl][Ser1]beta-human CGRP peptide (β-CGRP-analogue), or derivatives thereof. The CGRP compound can be used to induce myocardial perfusion recovery, in connection with AMI, by activating any CGRP family of receptors with a larger CGRP compound: CGRP potency ratio in the coronary artery than in the mesenteric artery.
Patent Family Records (6)
COMPOUNDS FOR USE IN INDUCING MYOCARDIAL PERFUSION RECOVERY
Epoqe Pharma Aps SAMS NIELSEN ANETTE, EDVINSSON LARS INGVAR HERBERT
2024, US-20240189393-A1
Compounds for use in inducing myocardial perfusion recovery
Epoqe Pharma Aps SAMS NIELSEN ANETTE, EDVINSSON LARS INGVAR HERBERT
2024, US-11890324-B2
COMPOUNDS FOR USE IN INDUCING MYOCARDIAL PERFUSION RECOVERY
Epoqe Pharma Aps, Patentselskabet Af 31 Maj 2021 Aps SAMS NIELSEN ANETTE, EDVINSSON LARS INGVAR HERBERT
2022, US-20220031809-A1
COMPOUNDS FOR USE IN INDUCING MYOCARDIAL PERFUSION RECOVERY
Epoqe Pharma Aps EDVINSSON LARS INGVAR HERBERT, SAMS NIELSEN ANETTE
2022, EP-3911359-A4
COMPOUNDS FOR USE IN INDUCING MYOCARDIAL PERFUSION RECOVERY
Patentselskabet Af 31 Maj 2021 Aps EDVINSSON LARS INGVAR HERBERT, SAMS NIELSEN ANETTE
2021, EP-3911359-A1
COMPOUNDS FOR USE IN INDUCING MYOCARDIAL PERFUSION RECOVERY
EDVINSSON LARS INGVAR HERBERT, SAMS NIELSEN ANETTE SAMS NIELSEN ANETTE, EDVINSSON LARS INGVAR HERBERT
2020, WO-2020130927-A1